IGF-1 DES is a recombinant Insulin-like Growth Factor-1 Des peptide developed using advanced recombinant DNA (rDNA) technology. Designed with a shorter amino acid sequence than native IGF-1, it delivers rapid, localized biological activity to support muscle hypertrophy, tissue regeneration, recovery, and athletic performance. IGF-1 DES is a shortened analogue of naturally occurring Insulin-like Growth Factor-1, modified by the removal of the first three amino acids. This structural modification reduces its binding to IGF-binding proteins (IGFBPs), resulting in greater local bioavailability and enhanced receptor interaction at the injection site. After administration, IGF-1 DES binds to IGF-1 receptors in skeletal muscle, activating cellular pathways responsible for protein synthesis, satellite cell activation, muscle cell proliferation, and tissue regeneration. Due to its short half-life and localized activity, IGF-1 DES is widely incorporated into targeted muscle development and post-workout recovery protocols, supporting lean muscle growth, muscle quality, and faster recovery. IGF-1 DES is commonly incorporated into performance and physique-focused protocols for: Dosage should be individualized according to training goals and professional guidance. General protocols commonly range from 250–1000 mcg daily, with administration typically performed via intramuscular injection into the target muscle. Cycle durations generally range between 4–8 weeks. Store unopened vials at 2–8°C, protect from direct sunlight, and refrigerate after reconstitution. Avoid freezing and maintain proper aseptic handling during preparation and administration. IGF-1 DES is generally well tolerated when used appropriately. Some individuals may experience mild injection-site irritation, headache, temporary fatigue, localized discomfort, or changes in blood glucose levels. If severe or persistent adverse reactions occur, discontinue use and consult a qualified healthcare professional. IGF-1 DES should be used only under professional medical supervision. Individuals with diabetes, impaired glucose tolerance, thyroid disorders, active malignancies, or other significant medical conditions should consult a healthcare provider before use. Regular monitoring of blood glucose and overall health is recommended during prolonged administration. IGF-1 DES is commonly incorporated into lean muscle gain, body recomposition, cutting, and recovery-focused protocols. It may complement other performance-oriented peptides and anabolic programs when appropriately planned. Stacking strategies should always be individualized according to training goals and undertaken under professional guidance. The information provided is for educational purposes only and is not intended as medical advice. Use IGF-1 DES only under professional supervision. Product images are for illustration purposes only and may differ from the actual product. Packaging and labeling are subject to change without prior notice.IGF-1 DES
Insulin-like Growth Factor-1 Des – 3 mg
How It Works
Frequently Used For
Dosage & Storage
Possible Side Effects
Precautions
Stacking Compatibility
Disclaimer